Medical Condition News

RSS

New technique use finger's pulse to measure stiffness in aorta

A University of Iowa physiologist has a new technique to measure the stiffness of the aorta, a common risk factor for heart disease. And it can be as simple as measuring the pulse in your finger.

5 Sep 2013

Researchers find no difference in stage-adjusted lung cancer mortality between blacks and whites

According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28 percent of all cancer deaths. While survival from lung cancer has improved since the early 1990s, racial differences in lung cancer survival persist such that blacks experience poorer 5-year survival for lung cancer compared to whites.

5 Sep 2013

High-income and better hygiene countries exhibit much higher rates of Alzheimer's

New research has found a "very significant" relationship between a nation's wealth and hygiene and the Alzheimer's "burden" on its population. High-income, highly industrialised countries with large urban areas and better hygiene exhibit much higher rates of Alzheimer's.

5 Sep 2013

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

A protein at the center of Parkinson's disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis, according to scientists led by UC San Francisco microbiologist and tuberculosis expert Jeffery Cox, PhD.

5 Sep 2013

Underweight women with CAD should gain weight to reduce risk of death

Being underweight increases the death risk of women with coronary artery disease (CAD) by 2-fold, according to research presented at the ESC Congress today by Dr Aziza Azimi from Denmark. The study suggests that underweight women with CAD should gain weight to reduce their risk of death.

5 Sep 2013

Research findings raise hope for new heart therapies

Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center recently found hope in an unlikely source - stem cells in cortical, or compact, bone.

5 Sep 2013

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Resveratrol, a polyphenolic compound, is synthesized in several plants and possesses beneficial biological effects, which include anti-oxidant, anti-inflammatory and anti-carcinogenic properties.

5 Sep 2013

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.

5 Sep 2013

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.

5 Sep 2013

People with CVD more likely to take preventive medicines when combined in one pill

People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.

5 Sep 2013

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn Inc. announced today that it has acquired from Galantos Pharma GmbH, Mainz, Germany all assets related to their Alzheimer's prescription drug candidate - Memogain. Memogain has completed an extensive preclinical development program and is ready to proceed into Phase 1 clinical trials in late 2013. The terms of the acquisition were not disclosed.

5 Sep 2013

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.

5 Sep 2013

Sirt1 Protein, Not Calorie Restriction, Extends Life Span

...

4 Sep 2013

Boosting Your Brain Power With Sleep

...

4 Sep 2013

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

A study published today in Aging Cell identifies a new tool to accurately analyze extremely rare mitochondrial DNA deletions associated with a range of diseases and disorders as well as aging. This approach, which relies on Droplet Digital PCR (ddPCR-) technology, will help researchers explore mtDNA deletions as potential disease biomarkers.

4 Sep 2013

Indicators of poor preoperative health predict risk of major medical complications

For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

4 Sep 2013

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc., and BioDelivery Sciences International, Inc. announced today that the companies have completed interim analyses of both the opioid naive and opioid experienced Phase III trials for BEMA Buprenorphine.

4 Sep 2013

Free reference and lifestyle tool now available for people affected by paralysis

For the first time, individuals living with paralysis and their caregivers can access the comprehensive Paralysis Resource Guide digitally on their smartphone, Nook, iPad or Kindle. The third edition of this vital resource, compiled and distributed by the Christopher & Dana Reeve Foundation Paralysis Resource Center, is a free reference and lifestyle tool for people affected by paralysis.

4 Sep 2013

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Prana Biotechnology today announced that Parkinson’s UK has awarded £150,000 (AU$260,000) to The University of Leeds to study the mechanism of action of PBT434.

4 Sep 2013

Research finding provides blueprint for understanding how the brain communicates with itself

During a normal conversation, your brain is constantly adjusting the volume to soften the sound of your own voice and boost the voices of others in the room.

4 Sep 2013

Medical Condition News

New technique use finger's pulse to measure stiffness in aorta

Researchers find no difference in stage-adjusted lung cancer mortality between blacks and whites

High-income and better hygiene countries exhibit much higher rates of Alzheimer's

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

Underweight women with CAD should gain weight to reduce risk of death

Research findings raise hope for new heart therapies

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

People with CVD more likely to take preventive medicines when combined in one pill

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sirt1 Protein, Not Calorie Restriction, Extends Life Span

Boosting Your Brain Power With Sleep

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

Indicators of poor preoperative health predict risk of major medical complications

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Free reference and lifestyle tool now available for people affected by paralysis

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Research finding provides blueprint for understanding how the brain communicates with itself

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News